Indianapolis, IN, United States of America

Stanislaw Rolski

This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1981-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stanislaw Rolski. Retrieved from https://idiyas.com/inventor/stanislaw-rolski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1981-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Stanislaw Rolski: Innovator in Pharmaceutical Chemistry

Introduction

Stanislaw Rolski is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase his innovative spirit and dedication to advancing medical science.

Latest Patents

Rolski's latest patents include "Naphthalene-1,5-disulfonate salts of dimeric indole-dihydroindole - Stable, biologically available, orally active 1,5-naphthalenedisulfonate salt of vinzolidine" and "Method of preparing vindesine sulfate - A method for preparing vindesine monosulfate, substantially free from hemisulfate and disulfate." These inventions reflect his expertise in creating stable and effective pharmaceutical compounds.

Career Highlights

He is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to contribute to the development of innovative therapies that improve patient outcomes.

Collaborations

Rolski collaborates with various professionals in the field, including his coworker Ralph R Pfeiffer. Their combined expertise enhances the research and development efforts at Eli Lilly.

Conclusion

Stanislaw Rolski's contributions to pharmaceutical chemistry through his patents and work at Eli Lilly and Company highlight his role as an influential inventor in the industry. His innovative approaches continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…